Fmr Llc - Jul 12, 2022 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
Other*, 10%+ Owner
Signature
Kevin M. Meagher, Duly authorized under Powers of Attorney, by and on behalf of FMR LLC and its direct and indirect subsidiaries, and Abigail P. Johnson
Stock symbol
VERV
Transactions as of
Jul 12, 2022
Transactions value $
-$3,386,520
Form type
4
Date filed
7/14/2022, 05:24 PM
Previous filing
Jul 6, 2022
Next filing
Jul 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERV Common Stock Sale -$2M -100K -13.63% $19.98 634K Jul 12, 2022 F-Prime Capital Partners Healthcare Fund V LP F1
transaction VERV Common Stock Sale -$1.39M -63K -9.94% $22.04 571K Jul 12, 2022 F-Prime Capital Partners Healthcare Fund V LP
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As the result of a scrivener's error, the Form 4 for Verve Therapeutics Inc. submitted on July 6, 2022, to the Commission for trades that occurred on July 1, 2022, misreported the amount of securities beneficially owned following the reported transactions as 773,729 common shares of Verve Therapeutics. The amount of securities beneficially owned by F-Prime Capital Partners Healthcare Fund V LP as of July 1, 2022 was 733,729 common shares following the disposal of 38,775 common shares.

Remarks:

Remark 1: Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. The address of Abigail P. Johnson is c/o FMR LLC, 245 Summer Street, Boston, MA 02110. Remark 2: The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the undersigned are the beneficial owners of any securities reported herein. Remark 3: The general partner of F-Prime Capital Partners Healthcare Fund V LP is F-Prime Capital Partners Healthcare Advisors Fund V LP (FPCPHA). FPCPHA is solely managed by Impresa Management LLC, the managing member of its general partner and its investment manager. Impresa Management LLC is owned, directly or indirectly, by various shareholders and employees of FMR LLC, including certain members of the Johnson family.